ALK and ROS1 Double-Rearranged Lung Squamous Cell Carcinoma Responding to Crizotinib Treatment: A Case Report

被引：11

作者：

Li, Qiong ^{[1
]}

Wu, Jian ^{[2
,3
]}

Yan, Li-Xu ^{[3
,4
]}

Huang, Jun-Wei ^{[2
,3
]}

Zhang, Zhou ^{[5
]}

Zhang, Jin-E ^{[3
,6
]}

Gao, Xing-Lin ^{[2
,3
]}

Luo, Ze-Ru ^{[2
,3
]}

Liu, Jing ^{[5
]}

Yang, Shi-Fang ^{[2
,3
]}

Liu, Yan-Hui ^{[3
,4
]}

机构：

[1] Southern Med Univ, Grad Shool, Guangzhou, Guangdong, Peoples R China

[2] Guangdong Gen Hosp, Dept Resp Med, Guangzhou, Guangdong, Peoples R China

[3] Guangdong Acad Med Sci, Guangzhou, Guangdong, Peoples R China

[4] Guangdong Gen Hosp, Dept Pathol, Guangzhou, Guangdong, Peoples R China

[5] Burning Rock Biotech, Guangzhou, Guangdong, Peoples R China

[6] Guangdong Gen Hosp, Dept Radiol, Guangzhou, Guangdong, Peoples R China

来源：

JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 12期

关键词：

CANCER; PATIENT;

D O I：

10.1016/j.jtho.2017.08.021

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：E193 / E197

页数：5

共 6 条

[1] Clinical and the Prognostic Characteristics of Lung Adenocarcinoma Patients with ROS1 Fusion in Comparison with Other Driver Mutations in East Asian Populations [J].

Chen, Yen-Fu ;

Hsieh, Min-Shu ;

Wu, Shang-Gin ;

Chang, Yih-Leong ;

Shih, Jin-Yuan ;

Liu, Yi-Nan ;

Tsai, Meng-Feng ;

Tsai, Tzu-Hsiu ;

Yu, Chong-Jen ;

Yang, James Chih-Hsin ;

Yang, Pan-Chyr .

JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (08) :1171-1179

[2] National Working Group Meeting on ALK diagnostics in lung cancer [J].

Cooper, Wendy ;

Fox, Stephen ;

O'Toole, Sandra ;

Morey, Adrienne ;

Frances, Glenn ;

Pavlakis, Nick ;

O'Byrne, Kenneth ;

Dettrick, Andrew ;

Leong, Trishe ;

Rathi, Vivek ;

Spagnolo, Dominic ;

Hemmings, Chris ;

Singh, Mahendra ;

Moffat, David ;

Tsao, Ming-Sound ;

Wilner, Keith ;

Buller, Richard ;

Pitman Lowenthal, Susan ;

Arifeen, Shams ;

Binko, Justin ;

Alam, Mahmood .

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 :11-17

[3] Clinical relevance of ROS1 rearrangements detection in advanced squamous cell carcinomas [J].

Gibelin, Cecilia ;

Avrillon, Virginie ;

De La Fouchardiere, Arnaud ;

Mc Leer-Florin, Anne ;

Lantuejoul, Sylvie ;

Fayette, Jerome .

LUNG CANCER, 2016, 102 :42-43

[4] First line crizotinib in anaplastic lymphoma kinase (ALK) rearranged squamous cell lung cancer [J].

Mikes, Romana E. ;

Jordan, Franziska ;

Hutarew, Georg ;

Studnicka, Michael .

LUNG CANCER, 2015, 90 (03) :614-616

[5] An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage [J].

Newman, Aaron M. ;

Bratman, Scott V. ;

To, Jacqueline ;

Wynne, Jacob F. ;

Eclov, Neville C. W. ;

Modlin, Leslie A. ;

Liu, Chih Long ;

Neal, Joel W. ;

Wakelee, Heather A. ;

Merritt, Robert E. ;

Shrager, Joseph B. ;

Loo, Billy W., Jr. ;

Alizadeh, Ash A. ;

Diehn, Maximilian .

NATURE MEDICINE, 2014, 20 (05) :552-558

[6] Activity of Crizotinib (PF02341066), a Dual Mesenchymal-Epithelial Transition (MET) and Anaplastic Lymphoma Kinase (ALK) Inhibitor, in a Non-small Cell Lung Cancer Patient with De Novo MET Amplification [J].

Ou, Sai-Hong Ignatius ;

Kwak, Eunice L. ;

Siwak-Tapp, Christina ;

Dy, Joni ;

Bergethon, Kristin ;

Clark, Jeffrey W. ;

Camidge, D. Ross ;

Solomon, Benjamin J. ;

Maki, Robert G. ;

Bang, Yung-Jue ;

Kim, Dong-Wan ;

Christensen, James ;

Tan, Weiwei ;

Wilner, Keith D. ;

Salgia, Ravi ;

Iafrate, A. John .

JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (05) :942-946

← 1 →